Autres langues Vicapsys Life Sciences, Inc.

Actions

VICP

US92560A1060

Marché Fermé - OTC Markets Autres places de cotation 19:25:39 28/06/2024			Varia. 5j.	Varia. 1 janv.
7 ^USD	+23,89 %		+157,35 %	+155,47 %

2023	Vicapsys Life Sciences, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2023	CI
2023	Vicapsys Life Sciences, Inc. annonce ses résultats pour le deuxième trimestre et les six mois terminés le 30 juin 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Vicapsys Life Sciences, Inc. announced that it has received $0.3036 million in funding	28/06/23
Vicapsys Life Sciences, Inc. announced that it expects to receive $0.3036 million in funding	27/06/23
Vicapsys Life Sciences : Change in Certifying Accountants - Form 8-K	17/05/23
VICAPSYS LIFE SCIENCES, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	17/05/23
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	14/04/23
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/04/23
Vicapsys Life Sciences, Inc. Auditor Raises 'Going Concern' Doubt	14/04/23
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	12/01/23
NOTE 2 - GOING CONCERN AND MANAGEMENT'S PLANS	21/11/22
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	21/11/22
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)	28/09/22
Vicapsys Life Sciences, Inc. Announces Board Changes	28/09/22
Vicapsys Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
Vicapsys Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22
Vicapsys Life Sciences, Inc. Appoints Federico Pier as Chief Executive Officer	12/04/22
VICAPSYS LIFE SCIENCES, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	12/04/22
VICAPSYS LIFE SCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	16/03/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Vicapsys Life Sciences, Inc.

Actions

VICP

US92560A1060

Autres langues

Filtres